This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Factory, Inc.. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Tamiki Katano: Innovator in Streptokinase Protein Development
Introduction
Tamiki Katano is a notable inventor based in Itano, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of mutated streptokinase proteins. Her innovative work has led to advancements in medical treatments and therapeutic applications.
Latest Patents
Tamiki Katano holds a patent for her invention titled "Mutated streptokinase proteins." This invention relates to a novel chemically synthesized gene that includes a base sequence coding for the primary amino acid sequence of natural-type streptokinase. The patent also covers a corresponding plasmid recombinant, a transformant, and a process for preparing streptokinase through the incubation of the transformant. Additionally, her invention includes novel streptokinase derivative proteins that possess streptokinase activity and a modified primary amino acid sequence, which is deficient in amino acid residues at the 373-position to the C-terminus.
Career Highlights
Tamiki Katano is associated with Otsuka Pharmaceutical Factory, Inc., where she has been able to apply her expertise in biotechnology. Her work has been instrumental in advancing the understanding and application of streptokinase proteins in medical science.
Collaborations
Throughout her career, Tamiki has collaborated with notable colleagues, including Setsuro Fujii, who is deceased, and Kenji Ono. These collaborations have contributed to her innovative research and development efforts.
Conclusion
Tamiki Katano's contributions to the field of biotechnology, particularly through her patented work on mutated streptokinase proteins, highlight her role as a significant inventor. Her innovative spirit continues to influence advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
